期刊
FREE RADICAL RESEARCH
卷 43, 期 2, 页码 156-164出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/10715760802644694
关键词
Alzheimer's disease; amyloid-beta; antioxidant; R-alpha lipoic acid; transgenic mice
资金
- National Institutes of Health
- Alzheimer's Association
- Philip Morris USA Inc.
- Philip Morris International.
- NATIONAL INSTITUTE ON AGING [R01AG026151] Funding Source: NIH RePORTER
Oxidative modifications are a hallmark of oxidative imbalance in the brains of individuals with Alzheimer's, Parkinson's and prion diseases and their respective animal models. While the causes of oxidative stress are relatively well-documented, the effects of chronically reducing oxidative stress on cognition, pathology and biochemistry require further clarification. To address this, young and aged control and amyloid-beta protein precursor-over-expressing mice were fed a diet with added R-alpha lipoic acid for 10 months to determine the effect of chronic antioxidant administration on the cognition and neuropathology and biochemistry of the brain. Both wild type and transgenic mice treated with R-alpha lipoic acid displayed significant reductions in markers of oxidative modifications. On the other hand, R-alpha lipoic acid had little effect on Y-maze performance throughout the study and did not decrease end-point amyloid-beta load. These results suggest that, despite the clear role of oxidative stress in mediating amyloid pathology and cognitive decline in ageing and A beta PP-transgenic mice, long-term antioxidant therapy, at levels within tolerable nutritional guidelines and which reduce oxidative modifications, have limited benefit.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据